Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

The Sphingolipid Rheostat: A Potential Target for Improving Pancreatic Islet Survival and Function

Volume:11   Issue: 4
Pp: 262-272
Claire F. Jessup, Claudine S. Bonder, Stuart M. Pitson and P. Toby H. Coates
DOI: 10.2174/187153011797881201

The Role of PPARβ/δ in the Management of Metabolic Syndrome and its Associated Cardiovascular Complications

Volume:11   Issue: 4
Pp: 273-284
Elisa Benetti, Nimesh S.A. Patel and Massimo Collino
DOI: 10.2174/187153011797881175

Ovulation, Implantation and Placentation in Females with Obesity and Metabolic Disorders: Life in the Balance

Volume:11   Issue: 4
Pp: 285-301
Antonio Gonzalez-Bulnes, Pilar Pallares and Cristina Ovilo
DOI: 10.2174/187153011797881193

FGF10 and FGF21 as Regulators in Adipocyte Development and Metabolism

Volume:11   Issue: 4
Pp: 302-309
Hiroya Ohta, Morichika Konishi and Nobuyuki Itoh
DOI: 10.2174/187153011797881166

Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator

Volume:11   Issue: 4
Pp: 326-333
Federica Laudisi, Manolo Sambucci and Claudio Pioli
DOI: 10.2174/187153011797881184

The Regulation of FoxP3-Expressing Regulatory T Cells

Volume:11   Issue: 4
Pp: 334-346
Rizwanul Haque, Fengyang Lei, Xiaofang Xiong and Jianxun Song
DOI: 10.2174/187153011797881157